FindTrial
Sign In

Classification of symblepharon and research on the individualized treatment of ocular surface reconstruction

Classification of symblepharon and research on the individualized treatment of ocular surface reconstruction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17012413
Enrollment
Unknown
Registered
2017-08-18
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

symblepharon

Interventions

Case series:Nil

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age will not be limited, sex is not limited; 2. Meet the internationally recognized diagnostic criteria for symblepharon; 3. With surgical indications: symblepharon affect visual acuity or appearance.

Exclusion criteria

Exclusion criteria: Severe cardiac, liver and renal insufficiency (myocardial ischemia or myocardial infarction, arrhythmia and cardiac dysfunction); patients who do not have legal capacity or limited legal capacity; researchers believe that is not suitable for participating in the trial in any other condition; refused to participate in clinical trials of patients.

Design outcomes

Primary

MeasureTime frame
change of tear film;—

Secondary

MeasureTime frame
clinical and pathological characteristics;—

Countries

China

Contacts

Public ContactFu Yao

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine

fuyaofy@sina.com+86 13671649059

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026